Wells Fargo & Company Allarity Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.22 - $31640.0 $1 - $158,200
5 Added 9.09%
60 $0
Q3 2022

Nov 14, 2022
BUY
$1.04 - $34160.0 $4 - $136,640
4 Added 7.84%
55 $0
Q2 2022

Aug 12, 2022
BUY
$1.11 - $2.99 $4 - $11
4 Added 8.51%
51 $0
Q1 2022

May 16, 2022
BUY
$1.93 - $10.75 $90 - $505
47 New
47 $0

Others Institutions Holding ALLR

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Allarity Therapeutics, Inc.

ALLR Quotes by TradingView
  • Ticker ALLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,260,200
  • Market Cap $35M
  • Description
  • Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; D...
More about ALLR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email